Literature DB >> 15952941

Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study.

S Weinmann1, B Janssen, W Gaebel.   

Abstract

OBJECTIVE: To evaluate guideline adherence in in-patient medication care of psychotic disorders.
METHOD: A total of 508 persons with psychotic disorders were included in a naturalistic multisite hospital study. Subjects were assessed weekly on mental state, social functioning, socioeconomic factors and medication prescriptions.
RESULTS: In total, 17% of individuals were prescribed antipsychotic dosages above the recommended value. Among those with persistent psychotic symptoms, 73% received insufficient antipsychotic drug management. About 58% of patients with depressive symptoms were not treated according to guidelines, and 53% of patients did not receive adequate management of side-effects from antipsychotic medications. Subjects with more than six previous psychiatric hospitalizations (OR 1.80, CI: 1.05-3.08) and those with a prominent thought disorder (OR 2.28, CI: 1.23-4.23) had a higher likelihood of not being treated according to guidelines.
CONCLUSION: Individuals with chronic and thought-disordered psychosis may be at a higher risk of receiving medication care not supported by guidelines. Copyright Blackwell Munksgaard 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952941     DOI: 10.1111/j.1600-0447.2005.00547.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  6 in total

1.  Public health and physician focused strategies to improve medication adherence in psychotic disorders.

Authors:  Saeed Farooq
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 2.  Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia.

Authors:  William G Honer; Allen E Thornton; Megan Sherwood; G William MacEwan; Tom S Ehmann; Richard Williams; Lili C Kopala; Ric Procyshyn; Alasdair M Barr
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  The Impact of Morphine Equivalent Daily Dose Threshold Guidelines on Prescribed Dose in a Workers' Compensation Population.

Authors:  Sara E Heins; Renan C Castillo
Journal:  Med Care       Date:  2020-03       Impact factor: 2.983

4.  Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia.

Authors:  Albert Bolstad; Ole A Andreassen; Jan I Røssberg; Ingrid Agartz; Ingrid Melle; Lars Tanum
Journal:  BMC Psychiatry       Date:  2011-08-03       Impact factor: 3.630

5.  Changes in Opioid Prescribing Following the Implementation of State Policies Limiting Morphine Equivalent Daily Dose in a Commercially Insured Population.

Authors:  Sara E Heins; Renan C Castillo
Journal:  Med Care       Date:  2021-09-01       Impact factor: 3.178

6.  Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.

Authors:  Rune A Kroken; Erik Johnsen; Torleif Ruud; Tore Wentzel-Larsen; Hugo A Jørgensen
Journal:  BMC Psychiatry       Date:  2009-05-16       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.